Total revenues increased by $2.8 billion, or 28.2%, to $12.9 billion for the year ended December 31, 2025, compared to $10.1 billion in 2024. Net income saw a substantial improvement, rising by $173.7 million from a net loss of $68.9 million in 2024 to a net income of $104.8 million in 2025. Adjusted EBITDA grew by $157.4 million, or 34.2%, reaching $617.6 million in 2025 from $460.2 million in 2024. Diluted income per share increased to $0.48 in 2025 from a diluted loss per share of $(0.34) in 2024. The company entered into a definitive agreement on January 17, 2025, to divest its Community Living business for $835 million in cash, expected to close in Q1 2026. Completed three acquisitions within the Provider Services segment in 2025 for approximately $247.0 million, including the Amedisys and LHC Branches Acquisition. Total outstanding debt decreased to $2,569.7 million as of December 31, 2025, from $2,683.3 million in 2024. Total liquidity, including cash and Revolving Credit Facility availability, increased to $565.58 million at year-end 2025 from $475.833 million at year-end 2024. The company is no longer a controlled company under Nasdaq rules as of the second fiscal quarter of 2025.